⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15551094 | 0.72 | — | — | |
| SCHEMBL7276793 | 0.70 | — | — | |
| SCHEMBL1887286 | 0.67 | — | — | |
| SCHEMBL9911578 | 0.67 | — | — | |
| SCHEMBL379482 | 0.67 | — | — | |
| SCHEMBL7642778 | 0.67 | — | — | |
| Methylglyoxal SCHEMBL47032 | 0.67 | — | — | |
| SCHEMBL279294 | 0.67 | — | — | |
| SCHEMBL15348318 | 0.67 | — | — | |
| SCHEMBL1867694 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11788138-B2 | Nucleic acid sequencing using affinity reagents | MGI TECH CO., LTD. (CN) | 2023-10-17 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| EP-4112741-A1 | STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES | MGI Tech Co., Ltd. (CN) | 2023-01-04 | — | — | EP | claimed |
| EP-3565905-B1 | NUCLEIC ACID SEQUENCING USING AFFINITY REAGENTS | MGI TECH CO LTD (CN) | 2022-05-25 | — | — | EP | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| US-20210206794-A1 | REVERSIBLY BLOCKED NUCLEOSIDE ANALOGUES AND THEIR USE | MGI TECH CO., LTD. (CN) | 2021-07-08 | — | — | US | claimed |
| US-10988501-B2 | Reversibly blocked nucleoside analogues and their use | MGI TECH CO., LTD. | 2021-04-27 | — | — | US | claimed |
| US-10851410-B2 | Nucleic acid sequencing using affinity reagents | MGI TECH CO., LTD. (CN) | 2020-12-01 | — | — | US | claimed |
| EP-3565905-A1 | STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES | MGI Tech Co., Ltd. (CN) | 2019-11-13 | — | — | EP | claimed |
| EP-1086105-B1 | FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS | US GOV HEALTH & HUMAN SERV (US) | 2006-03-01 | — | — | EP | claimed |
| US-6919464-B1 | Synthetic derivatives of 21-butenyl and related spinosyns | DOW AGROSCIENCES LLC (US) | 2005-07-19 | — | — | US | claimed |
| EP-1370566-A1 | SYNTHETIC DERIVATIVES OF 21-BUTENYL AND RELATED SPINOSYNS | Dow AgroSciences LLC (US) | 2003-12-17 | — | — | EP | claimed |
| US-6610684-B2 | Antiproliferative agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2003-08-26 | — | — | US | claimed |
| WO-2002077004-A1 | SYNTHETIC DERIVATIVES OF 21-BUTENYL AND RELATED SPINOSYNS | DOW AGROSCIENCES LLC (US) | 2002-10-03 | — | — | WO | claimed |
| US-20020042412-A1 | Fused azepinone cyclin dependent kinase inhibitors | HEALTH AND HUMAN SERVICES, DEPARTMENT OF, GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE, THE | 2002-04-11 | — | — | US | claimed |
| US-6268310-B1 | CONTROLLING WEEDS | NIPPON SODA CO., LTD. (JP) | 2001-07-31 | — | — | US | claimed |
| EP-1086105-A1 | FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2001-03-28 | — | — | EP | claimed |
| WO-1999065910-A9 | FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS | US HEALTH (US) | 2000-03-16 | — | — | WO | claimed |
| WO-1999065910-A1 | FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-12-23 | — | — | WO | claimed |